ARTICLE | Management Tracks
Di Donato to leave Immunocore
Plus: FDA’s Mantha, Fakhouri and Liu lead CDER’s AI Council, and an update from BC Platforms
August 30, 2024 1:11 AM UTC
Brian Di Donato will leave Immunocore Holdings plc (NASDAQ:IMCR) on Dec. 31 as CFO and head of strategy to become CEO of an undisclosed, San Diego-based biotech. Immunocore, which is developing TCR bispecifics to treat cancer, infectious diseases and autoimmune diseases, added that it’s looking for a new CFO.
FDA named Sri Mantha, Tala Fakhouri and Qi Liu co-leaders of CDER’s AI Council, which the agency established to provide oversight, coordination, and consolidation of AI activities. Mantha, Fakhouri and Liu are from the agency’s offices of strategic programs, medical policy and translational sciences, respectively. ...